Eckart Laack
- Pulmonary and Respiratory Medicine top 1%
- Oncology top 1%
- Molecular Biology
- Cancer Research top 5%
- Surgery
- Co-authors
- William J. JohnLuis Paz‐AresFilippo de MarinisPaolo BidoliMichael ThomasYi‐Long WuMaciej KrzakowskiMircea Dediu
- Topics
- Lung Cancer Treatments and Mutations (40 papers)Lung Cancer Research Studies (23 papers)Lung Cancer Diagnosis and Treatment (14 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Eckart Laack
58 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Pulmonary and Respiratory Medicine 2.2k
- Oncology 2.0k
- Molecular Biology 619
- Cancer Research 408
- Surgery 195
Countries citing papers authored by Eckart Laack
This map shows the geographic impact of Eckart Laack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckart Laack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckart Laack more than expected).
Fields of papers citing papers by Eckart Laack
This network shows the impact of papers produced by Eckart Laack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckart Laack. The network helps show where Eckart Laack may publish in the future.
Co-authorship network of co-authors of Eckart Laack
This figure shows the co-authorship network connecting the top 25 collaborators of Eckart Laack. A scholar is included among the top collaborators of Eckart Laack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eckart Laack. Eckart Laack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 18 | |
| 6 | PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancerbreakdown → | 438 |
| 7 | Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trialbreakdown → | 447 |
| 8 | 27 | |
| 9 | 56 | |
| 10 | 5 | |
| 11 | 22 | |
| 12 | 3 | |
| 13 | 16 | |
| 14 | 3 | |
| 15 | 29 | |
| 16 | 38 | |
| 17 | 13 | |
| 18 | 18 | |
| 19 | 19 | |
| 20 | 27 |
About Eckart Laack
Eckart Laack is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 61 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (23 papers) and Lung Cancer Diagnosis and Treatment (14 papers). The work is most often cited by research in Oncology (2.0k citations), Pulmonary and Respiratory Medicine (2.2k citations) and Cancer Research (408 citations). Eckart Laack has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include William J. John, Luis Paz‐Ares, Filippo de Marinis, Paolo Bidoli, Michael Thomas, Yi‐Long Wu, Maciej Krzakowski, Mircea Dediu, Symantha Melemed and Nadia Chouaki. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.